201 related articles for article (PubMed ID: 24098538)
1. Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo.
Wang WJ; Yao Y; Jiang LL; Hu TH; Ma JQ; Liao ZJ; Yao JT; Li DF; Wang SH; Nan KJ
PLoS One; 2013; 8(10):e76596. PubMed ID: 24098538
[TBL] [Abstract][Full Text] [Related]
2. Increased LEF1 expression and decreased Notch2 expression are strong predictors of poor outcomes in colorectal cancer patients.
Wang WJ; Yao Y; Jiang LL; Hu TH; Ma JQ; Ruan ZP; Tian T; Guo H; Wang SH; Nan KJ
Dis Markers; 2013; 35(5):395-405. PubMed ID: 24223455
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-26b represses colon cancer cell proliferation by inhibiting lymphoid enhancer factor 1 expression.
Zhang Z; Kim K; Li X; Moreno M; Sharp T; Goodheart MJ; Safe S; Dupuy AJ; Amendt BA
Mol Cancer Ther; 2014 Jul; 13(7):1942-51. PubMed ID: 24785257
[TBL] [Abstract][Full Text] [Related]
4. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.
Wang S; Dong Y; Zhang Y; Wang X; Xu L; Yang S; Li X; Dong H; Xu L; Su L; Ng SS; Chang Z; Sung JJ; Zhang X; Yu J
Oncogene; 2015 May; 34(20):2575-85. PubMed ID: 25023701
[TBL] [Abstract][Full Text] [Related]
5. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
6. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1.
Liu Y; Yan W; Zhang W; Chen L; You G; Bao Z; Wang Y; Wang H; Kang C; Jiang T
Oncol Rep; 2012 Sep; 28(3):1013-21. PubMed ID: 22766851
[TBL] [Abstract][Full Text] [Related]
7. SERPINA3 Silencing Inhibits the Migration, Invasion, and Liver Metastasis of Colon Cancer Cells.
Cao LL; Pei XF; Qiao X; Yu J; Ye H; Xi CL; Wang PY; Gong ZL
Dig Dis Sci; 2018 Sep; 63(9):2309-2319. PubMed ID: 29855767
[TBL] [Abstract][Full Text] [Related]
8. Expression and proliferation-promoting role of lymphoid enhancer-binding factor 1 in human clear cell renal carcinoma.
Shang D; Bi R; Han T; Wang D; Tian Y; Liu Y
Cancer Invest; 2014 Aug; 32(7):368-74. PubMed ID: 24897388
[TBL] [Abstract][Full Text] [Related]
9. LEF1 Enhances the Progression of Colonic Adenocarcinoma via Remodeling the Cell Motility Associated Structures.
Xiao L; Zhang C; Li X; Jia C; Chen L; Yuan Y; Gao Q; Lu Z; Feng Y; Zhao R; Zhao X; Cheng S; Shu Z; Xu J; Duan W; Nie G; Hou Y
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639214
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma.
Zhao Y; Zhu J; Shi B; Wang X; Lu Q; Li C; Chen H
J Exp Clin Cancer Res; 2019 Jul; 38(1):304. PubMed ID: 31296250
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA miR-29a Inhibits Colon Cancer Progression by Downregulating B7-H3 Expression: Potential Molecular Targets for Colon Cancer Therapy.
Wang J; Chen X; Xie C; Sun M; Hu C; Zhang Z; Luan L; Zhou J; Zhou J; Zhu X; Ouyang J; Dong X; Li D; Zhang J; Zhao X
Mol Biotechnol; 2021 Sep; 63(9):849-861. PubMed ID: 34100183
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
13. Piwil2 modulates the proliferation and metastasis of colon cancer via regulation of matrix metallopeptidase 9 transcriptional activity.
Li D; Sun X; Yan D; Huang J; Luo Q; Tang H; Peng Z
Exp Biol Med (Maywood); 2012 Oct; 237(10):1231-40. PubMed ID: 23104504
[TBL] [Abstract][Full Text] [Related]
14. Effects of microRNA-708 on Epithelial-Mesenchymal Transition, Cell Proliferation and Apoptosis in Melanoma Cells by Targeting LEF1 through the Wnt Signaling Pathway.
Song XF; Wang QH; Huo R
Pathol Oncol Res; 2019 Jan; 25(1):377-389. PubMed ID: 29138985
[TBL] [Abstract][Full Text] [Related]
15. Hes1 is involved in the self-renewal and tumourigenicity of stem-like cancer cells in colon cancer.
Gao F; Zhang Y; Wang S; Liu Y; Zheng L; Yang J; Huang W; Ye Y; Luo W; Xiao D
Sci Rep; 2014 Feb; 4():3963. PubMed ID: 24492635
[TBL] [Abstract][Full Text] [Related]
16. Increased cAMP in monocytes augments Notch signaling mechanisms by elevating RBP-J and transducin-like enhancer of Split (TLE).
Larabee JL; Shakir SM; Barua S; Ballard JD
J Biol Chem; 2013 Jul; 288(30):21526-36. PubMed ID: 23775085
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration.
Zhao Y; Li C; Huang L; Niu S; Lu Q; Gong D; Huang S; Yuan Y; Chen H
Cancer Med; 2018 Aug; 7(8):3977-3987. PubMed ID: 29974668
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of LEF1/TCFs family members in colonic carcinogenesis.
Han W; He L; Cao B; Zhao X; Zhang K; Li Y; Beck P; Zhou Z; Tian Y; Cheng S; Wang H
Mol Carcinog; 2017 Nov; 56(11):2372-2381. PubMed ID: 27433921
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression.
Liu DC; Song LL; Liang Q; Hao L; Zhang ZG; Han CH
J Cell Physiol; 2019 Aug; 234(8):12727-12744. PubMed ID: 30613973
[TBL] [Abstract][Full Text] [Related]
20. microRNA-219-5p inhibits epithelial-mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1.
Huang LX; Hu CY; Jing L; Wang MC; Xu M; Wang J; Wang Y; Nan KJ; Wang SH
Cancer Sci; 2017 Oct; 108(10):1985-1995. PubMed ID: 28771881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
